The United States will begin participating in an international collaboration to distribute COVID-19 vaccines more equitably around the world after President Joe Biden reversed the Trump administration’s withdrawal from the World Health Organization on his first day in office. Richard Marlink, the director of Rutgers Global Health Institute, discusses the impact COVAX, the global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, will have on ending the COVID-19 pandemic and strengthening global health. To read the full story.
Recent Posts
- Antibiotics and Antifungals May Slightly Affect Parkinson’s Risk, Study Finds.
- Where Did Americans Find Information for the 2024 Election?
- The HELIX At Rutgers Gets $50M In Research Funding From The NIH.
- New NJACTS Publication
- What if your baby’s organs are filled with plastic? New research reveals disturbing truth.
Categories
- Community (2,062)
- Covid (978)
- CTO Events (5)
- News (2,621)
- Pilots (20)